156 related articles for article (PubMed ID: 9417486)
1. [Selenium administration in sepsis patients].
Gärtner R; Angstwurm MW; Schottdorf J
Med Klin (Munich); 1997 Sep; 92 Suppl 3():12-4. PubMed ID: 9417486
[TBL] [Abstract][Full Text] [Related]
2. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.
Angstwurm MW; Schottdorf J; Schopohl J; Gaertner R
Crit Care Med; 1999 Sep; 27(9):1807-13. PubMed ID: 10507602
[TBL] [Abstract][Full Text] [Related]
3. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
[TBL] [Abstract][Full Text] [Related]
4. [Significance of selenium in intensive care medicine. Clinical studies of patients with SIRS/sepsis syndrome].
Gärtner R; Angstwurm M
Med Klin (Munich); 1999 Oct; 94 Suppl 3():54-7. PubMed ID: 10554531
[TBL] [Abstract][Full Text] [Related]
5. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation.
Manzanares W; Biestro A; Torre MH; Galusso F; Facchin G; Hardy G
Intensive Care Med; 2011 Jul; 37(7):1120-7. PubMed ID: 21445641
[TBL] [Abstract][Full Text] [Related]
6. [Selenium administration in patients with sepsis syndrome. A prospective randomized study].
Zimmermann T; Albrecht S; Kühne H; Vogelsang U; Grützmann R; Kopprasch S
Med Klin (Munich); 1997 Sep; 92 Suppl 3():3-4. PubMed ID: 9417494
[TBL] [Abstract][Full Text] [Related]
7. High-dose selenium for critically ill patients with systemic inflammation: pharmacokinetics and pharmacodynamics of selenious acid: a pilot study.
Manzanares W; Biestro A; Galusso F; Torre MH; Mañáy N; Facchin G; Hardy G
Nutrition; 2010 Jun; 26(6):634-40. PubMed ID: 20080034
[TBL] [Abstract][Full Text] [Related]
8. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients.
Angstwurm MW; Schopohl J; Gaertner R
Eur J Endocrinol; 2004 Jul; 151(1):47-54. PubMed ID: 15248821
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium.
Brodska H; Valenta J; Malickova K; Kohout P; Kazda A; Drabek T
J Trace Elem Med Biol; 2015; 31():25-32. PubMed ID: 26004888
[TBL] [Abstract][Full Text] [Related]
10. [Effect of selenium administration on various laboratory parameters in patients with acute pancreatitis].
Wollschläger S; Ludwig K; Meissner D; Porst H
Med Klin (Munich); 1997 Sep; 92 Suppl 3():22-4. PubMed ID: 9417490
[TBL] [Abstract][Full Text] [Related]
11. [Pharmaconutrition with parenteral selenium in sepsis].
Langlois PL; de Oliveira Figliolino LF; Hardy G; Manzanares W
Med Intensiva; 2014 Apr; 38(3):173-80. PubMed ID: 24021703
[TBL] [Abstract][Full Text] [Related]
12. [Effect of selenium administration on various laboratory parameters of patients at risk for sepsis syndrome].
Lehmann C; Egerer K; Weber M; Krausch D; Wauer H; Newie T; Kox WJ
Med Klin (Munich); 1997 Sep; 92 Suppl 3():14-6. PubMed ID: 9417487
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis.
Sakr Y; Maia VP; Santos C; Stracke J; Zeidan M; Bayer O; Reinhart K
Crit Care; 2014 Apr; 18(2):R68. PubMed ID: 24716537
[TBL] [Abstract][Full Text] [Related]
14. High-dose selenium substitution in sepsis: a prospective randomized clinical trial.
Valenta J; Brodska H; Drabek T; Hendl J; Kazda A
Intensive Care Med; 2011 May; 37(5):808-15. PubMed ID: 21347869
[TBL] [Abstract][Full Text] [Related]
15. [Selenium administration in severe inflammatory surgical diseases and burns in childhood].
Börner J; Zimmermann T; Albrecht S; Roesner D
Med Klin (Munich); 1997 Sep; 92 Suppl 3():17-9. PubMed ID: 9417488
[TBL] [Abstract][Full Text] [Related]
16. [The value of selenotherapy in patients with mucoviscidosis].
Kauf E; Janitzky E; Vogt L; Winnefeld K; Dawczynski H; Forberger M; Jahreis G; Vogel H
Med Klin (Munich); 1995 Jan; 90 Suppl 1():41-5. PubMed ID: 7715584
[TBL] [Abstract][Full Text] [Related]
17. SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX-trial): study design of an international multicenter randomized double-blinded controlled trial of high dose sodium-selenite administration in high-risk cardiac surgical patients.
Stoppe C; McDonald B; Rex S; Manzanares W; Whitlock R; Fremes S; Fowler R; Lamarche Y; Meybohm P; Haberthür C; Rossaint R; Goetzenich A; Elke G; Day A; Heyland DK
Trials; 2014 Aug; 15():339. PubMed ID: 25169040
[TBL] [Abstract][Full Text] [Related]
18. [Significance of selenium in regulation of inflammatory response by transcription factors in polytrauma patients. A clinical study].
von Gagern G; Zimmermann T; Albrecht S; Bachmann L; Zwipp H; Saeger HD
Med Klin (Munich); 1999 Oct; 94 Suppl 3():62-5. PubMed ID: 10554533
[TBL] [Abstract][Full Text] [Related]
19. [Selenium in phenylketonuria patients. Effects of sodium selenite administration].
Kauf E; Seidel J; Winnefeld K; Dawczynski H; Häfer R; Stein F; Vogt L
Med Klin (Munich); 1997 Sep; 92 Suppl 3():31-4. PubMed ID: 9417495
[TBL] [Abstract][Full Text] [Related]
20. Pharmaconutrition with selenium in critically ill patients: what do we know?
Manzanares W; Langlois PL; Heyland DK
Nutr Clin Pract; 2015 Feb; 30(1):34-43. PubMed ID: 25524883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
